SOPHiA GENETICS SA (SOPH)

SOPHiA GENETICS experienced significant insider activity recently, with 54 transactions recorded over 90 days. While executives like the CEO and CFO made notable purchases totaling $278,388, broader selling pressure persists, amounting to over $3.3 million. This follows a challenging earnings report where the company missed expectations, contributing to a 10.1% decline in stock value.
Ticker: SOPH Exchange: NSM


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for SOPHiA GENETICS SA. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Van Well Daan Chief Legal Officer Officer
Transaction date
Planned sale
Price
144.20
Quantity 65,823 +31.3%
Value US$3,507,549
DAAN GUIDO MARIA VAN WELL Officer Officer
Transaction date
Proposed sale
Price
330.55
Quantity 65,459
Value US$3,832,275
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
166.78
Quantity 38,167 +13.6%
Value US$2,085,222
Menu Philippe Chief Medical Officer Officer
Transaction date
Planned sale
Price
7.68
Quantity 1,000 -2.6%
Value US$100,000
HIBBS KATHY L Non-Executive Director
Transaction date
Planned sale
Price
7.76
Quantity 1,000 -6.4%
Value US$100,000
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
7.76
Quantity 1,000 -0.3%
Value US$100,000
Van Well Daan Chief Legal Officer Officer
Transaction date
Planned sale
Price
7.44
Quantity 1,000 -0.4%
Value US$100,000
DAAN GUIDO MARIA VAN WELL Officer Officer
Transaction date
Proposed sale
Price
7.14
Quantity 1,000
Value US$100,000
2.2
CARDOZA GEORGE Chief Financial Officer Officer
Transaction date
Purchase
Price
7.06
Quantity 1,000 +6.5%
Value US$100,000
Muken Ross Chief Executive Officer Executive Director
Transaction date
Purchase
Price
6.86
Quantity 1,000 +3.0%
Value US$100,000
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
7.18
Quantity 4,000 -0.7%
Value US$28,727
Menu Philippe Chief Medical Officer Officer
Transaction date
Planned sale
Price
7.26
Quantity 5,000 -2.5%
Value US$36,303
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
7.26
Quantity 8,500 -0.3%
Value US$61,671
Valente Manuela Chief People Officer Officer
Transaction date
Planned sale
Price
8.13
Quantity 4,240 -2.0%
Value US$34,487
1.7
Puylaert Kevin Chief Sales Officer Officer
Transaction date
Sale
Price
7.92
Quantity 31 -0.0%
Value US$246
1.7
Puylaert Kevin Chief Sales Officer Officer
Transaction date
Sale
Price
8.06
Quantity 185 -0.1%
Value US$1,491
Verma Abhimanyu Chief Technology Officer Officer
Transaction date
Planned sale
Price
8.12
Quantity 5,284 -3.1%
Value US$42,929
Van Well Daan Chief Legal Officer Officer
Transaction date
Planned sale
Price
8.12
Quantity 6,168 -1.8%
Value US$50,100
Muken Ross Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
8.13
Quantity 9,838 -1.5%
Value US$79,971
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
8.13
Quantity 40,172 -1.2%
Value US$326,526
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
8.12
Quantity 7,394 -1.3%
Value US$60,075
2.2
CARDOZA GEORGE Chief Financial Officer Officer
Transaction date
Planned sale
Price
8.10
Quantity 1,592 -0.5%
Value US$12,897
Menu Philippe Chief Medical Officer Officer
Transaction date
Planned sale
Price
8.13
Quantity 7,394 -3.5%
Value US$60,100
ZHENYU XU Officer Officer
Transaction date
Proposed sale
Price
8.07
Quantity 19,394
Value US$156,510
ROSS J MUKEN Director; Officer Executive Director
Transaction date
Proposed sale
Price
8.07
Quantity 9,838
Value US$79,393
PHILIPPE MENU Officer Officer
Transaction date
Proposed sale
Price
8.07
Quantity 22,394
Value US$180,720
MANUELA VALENTE Officer Officer
Transaction date
Proposed sale
Price
8.07
Quantity 4,240
Value US$34,217
2.2
GEORGE CARDOZA Officer Officer
Transaction date
Proposed sale
Price
8.07
Quantity 1,592
Value US$12,847
JURGI CAMBLONG Director; Officer Executive Director
Transaction date
Proposed sale
Price
8.07
Quantity 65,672
Value US$529,973
Muken Ross Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
8.33
Quantity 422 -0.1%
Value US$3,515
2.2
CARDOZA GEORGE Chief Financial Officer Officer
Transaction date
Planned sale
Price
8.33
Quantity 774 -0.3%
Value US$6,447
2.2
GEORGE CARDOZA Officer Officer
Transaction date
Proposed sale
Price
8.19
Quantity 774
Value US$6,339
ROSS J MUKEN Director; Officer Executive Director
Transaction date
Proposed sale
Price
8.19
Quantity 422
Value US$3,456
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
7.88
Quantity 4,000 -0.7%
Value US$31,538
Menu Philippe Chief Medical Officer Officer
Transaction date
Planned sale
Price
7.88
Quantity 5,000 -2.3%
Value US$39,416
Van Well Daan Chief Legal Officer Officer
Transaction date
Planned sale
Price
7.63
Quantity 6,168 -1.8%
Value US$47,089
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
7.66
Quantity 8,500 -0.2%
Value US$65,120
HIBBS KATHY L Non-Executive Director
Transaction date
Planned sale
Price
8.13
Quantity 6,250 -6.1%
Value US$50,818
HIBBS KATHY L Non-Executive Director
Transaction date
Planned sale
Price
8.13
Quantity 6,250 -6.1%
Value US$50,818
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
8.91
Quantity 10,000 -1.8%
Value US$89,096
ZHENYU XU Officer Officer
Transaction date
Proposed sale
Price
8.53
Quantity 14,000
Value US$119,420
HIBBS KATHY L Non-Executive Director
Transaction date
Planned sale
Price
8.68
Quantity 6,250 -5.7%
Value US$54,233
Menu Philippe Chief Medical Officer Officer
Transaction date
Planned sale
Price
8.68
Quantity 5,000 -2.3%
Value US$43,396
KATHY L HIBBS Director Non-Executive Director
Transaction date
Proposed sale
Price
8.45
Quantity 18,750
Value US$158,438
Verma Abhimanyu Chief Technology Officer Officer
Transaction date
Planned sale
Price
8.80
Quantity 5,000 -2.8%
Value US$44,000
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
8.40
Quantity 5,408 -0.9%
Value US$45,447
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
8.41
Quantity 4,592 -0.8%
Value US$38,609
ZHENYU XU Officer Officer
Transaction date
Proposed sale
Price
8.28
Quantity 6,000
Value US$49,680
Verma Abhimanyu Chief Technology Officer Officer
Transaction date
Planned sale
Price
8.20
Quantity 5,000 -2.7%
Value US$41,000
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
7.94
Quantity 10,000 -1.7%
Value US$79,427
Valente Manuela Chief People Officer Officer
Transaction date
Planned sale
Price
7.94
Quantity 10,000 -4.5%
Value US$79,439
MANUELA VALENTE Officer Officer
Transaction date
Proposed sale
Price
7.62
Quantity 10,000
Value US$76,200
ZHENYU XU Officer Officer
Transaction date
Proposed sale
Price
7.62
Quantity 8,000
Value US$60,960
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
7.52
Quantity 4,000 -0.7%
Value US$30,076
Menu Philippe Chief Medical Officer Officer
Transaction date
Planned sale
Price
7.52
Quantity 5,000 -2.2%
Value US$37,580
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
7.61
Quantity 8,500 -0.2%
Value US$64,669
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
7.23
Quantity 20,000 -0.6%
Value US$144,540
Verma Abhimanyu Chief Technology Officer Officer
Transaction date
Planned sale
Price
7.60
Quantity 5,000 -2.7%
Value US$38,000
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
7.48
Quantity 10,000 -1.7%
Value US$74,759
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
7.02
Quantity 7,000 -1.2%
Value US$49,152
ZHENYU XU Officer Officer
Transaction date
Proposed sale
Price
6.69
Quantity 22,000
Value US$147,180
JURGI CAMBLONG Director; Officer Executive Director
Transaction date
Proposed sale
Price
6.69
Quantity 20,000
Value US$133,800
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
7.00
Quantity 3,000 -0.5%
Value US$21,013
Xu Zhenyu Chief Scientific Officer Officer
Transaction date
Planned sale
Price
6.92
Quantity 10,000 -1.6%
Value US$69,168
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
6.92
Quantity 20,000 -0.6%
Value US$138,412
Verma Abhimanyu Chief Technology Officer Officer
Transaction date
Planned sale
Price
6.95
Quantity 5,000 -2.6%
Value US$34,772
ZHENYU XU Officer Officer
Transaction date
Proposed sale
Price
5.69
Quantity 10,000
Value US$56,900
JURGI CAMBLONG Director; Officer Executive Director
Transaction date
Proposed sale
Price
5.69
Quantity 20,000
Value US$113,800
Menu Philippe Chief Medical Officer Officer
Transaction date
Planned sale
Price
5.66
Quantity 5,000 -2.2%
Value US$28,306
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
6.63
Quantity 20,000 -0.6%
Value US$132,654
JURGI CAMBLONG Director; Officer Executive Director
Transaction date
Proposed sale
Price
6.33
Quantity 37,000
Value US$234,210
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
6.17
Quantity 4,581 -0.1%
Value US$28,244
Camblong Jurgi Executive Chairman Executive Director
Transaction date
Planned sale
Price
6.32
Quantity 19,800 -0.6%
Value US$125,201
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-17 2026-11-16 PlS Planned sale

Chief Legal Officer

Officer
65,823 +31.3%
144.20
US$3,507,549
65,823 +31.3% 144.20 US$3,507,549
2026-11-16 2026-11-16 PrS Proposed sale

Officer

Officer
65,459
330.55
US$3,832,275
65,459 330.55 US$3,832,275
2026-11-16 2026-11-13 PlS Planned sale

Chief Scientific Officer

Officer
38,167 +13.6%
166.78
US$2,085,222
38,167 +13.6% 166.78 US$2,085,222
2026-11-16 2026-11-12 PlS Planned sale

Chief Medical Officer

Officer
1,000 -2.6%
7.68
US$100,000
1,000 -2.6% 7.68 US$100,000
2026-11-12 2026-11-10 PlS Planned sale Non-Executive Director
1,000 -6.4%
7.76
US$100,000
1,000 -6.4% 7.76 US$100,000
2026-11-12 2026-11-10 PlS Planned sale

Executive Chairman

Executive Director
1,000 -0.3%
7.76
US$100,000
1,000 -0.3% 7.76 US$100,000
2026-11-12 2026-11-09 PlS Planned sale

Chief Legal Officer

Officer
1,000 -0.4%
7.44
US$100,000
1,000 -0.4% 7.44 US$100,000
2026-11-09 2026-11-09 PrS Proposed sale

Officer

Officer
1,000
7.14
US$100,000
1,000 7.14 US$100,000
2026-11-09 2026-11-06 B Purchase

Chief Financial Officer

Officer
1,000 +6.5%
7.06
US$100,000
1,000 +6.5% 7.06 US$100,000
2026-11-09 2026-11-06 B Purchase

Chief Executive Officer

Executive Director
1,000 +3.0%
6.86
US$100,000
1,000 +3.0% 6.86 US$100,000
2026-10-14 2026-10-13 PlS Planned sale

Chief Scientific Officer

Officer
4,000 -0.7%
7.18
US$28,727
4,000 -0.7% 7.18 US$28,727
2026-10-14 2026-10-12 PlS Planned sale

Chief Medical Officer

Officer
5,000 -2.5%
7.26
US$36,303
5,000 -2.5% 7.26 US$36,303
2026-10-14 2026-10-12 PlS Planned sale

Executive Chairman

Executive Director
8,500 -0.3%
7.26
US$61,671
8,500 -0.3% 7.26 US$61,671
2026-10-07 2026-10-05 PlS Planned sale

Chief People Officer

Officer
4,240 -2.0%
8.13
US$34,487
4,240 -2.0% 8.13 US$34,487
2026-10-07 2026-10-05 S Sale

Chief Sales Officer

Officer
31 -0.0%
7.92
US$246
31 -0.0% 7.92 US$246
2026-10-07 2026-10-05 S Sale

Chief Sales Officer

Officer
185 -0.1%
8.06
US$1,491
185 -0.1% 8.06 US$1,491
2026-10-07 2026-10-05 PlS Planned sale

Chief Technology Officer

Officer
5,284 -3.1%
8.12
US$42,929
5,284 -3.1% 8.12 US$42,929
2026-10-07 2026-10-05 PlS Planned sale

Chief Legal Officer

Officer
6,168 -1.8%
8.12
US$50,100
6,168 -1.8% 8.12 US$50,100
2026-10-07 2026-10-05 PlS Planned sale

Chief Executive Officer

Executive Director
9,838 -1.5%
8.13
US$79,971
9,838 -1.5% 8.13 US$79,971
2026-10-07 2026-10-05 PlS Planned sale

Executive Chairman

Executive Director
40,172 -1.2%
8.13
US$326,526
40,172 -1.2% 8.13 US$326,526
2026-10-07 2026-10-05 PlS Planned sale

Chief Scientific Officer

Officer
7,394 -1.3%
8.12
US$60,075
7,394 -1.3% 8.12 US$60,075
2026-10-07 2026-10-05 PlS Planned sale

Chief Financial Officer

Officer
1,592 -0.5%
8.10
US$12,897
1,592 -0.5% 8.10 US$12,897
2026-10-07 2026-10-05 PlS Planned sale

Chief Medical Officer

Officer
7,394 -3.5%
8.13
US$60,100
7,394 -3.5% 8.13 US$60,100
2026-10-05 2026-10-05 PrS Proposed sale

Officer

Officer
19,394
8.07
US$156,510
19,394 8.07 US$156,510
2026-10-05 2026-10-05 PrS Proposed sale

Officer

Officer
6,168
8.07
US$49,776
6,168 8.07 US$49,776
2026-10-05 2026-10-05 PrS Proposed sale

Director; Officer

Executive Director
9,838
8.07
US$79,393
9,838 8.07 US$79,393
2026-10-05 2026-10-05 PrS Proposed sale

Officer

Officer
22,394
8.07
US$180,720
22,394 8.07 US$180,720
2026-10-05 2026-10-05 PrS Proposed sale

Officer

Officer
4,240
8.07
US$34,217
4,240 8.07 US$34,217
2026-10-05 2026-10-05 PrS Proposed sale

Officer

Officer
1,592
8.07
US$12,847
1,592 8.07 US$12,847
2026-10-05 2026-10-05 PrS Proposed sale

Director; Officer

Executive Director
65,672
8.07
US$529,973
65,672 8.07 US$529,973
2026-09-22 2026-09-21 PlS Planned sale

Chief Executive Officer

Executive Director
422 -0.1%
8.33
US$3,515
422 -0.1% 8.33 US$3,515
2026-09-22 2026-09-21 PlS Planned sale

Chief Financial Officer

Officer
774 -0.3%
8.33
US$6,447
774 -0.3% 8.33 US$6,447
2026-09-21 2026-09-21 PrS Proposed sale

Officer

Officer
774
8.19
US$6,339
774 8.19 US$6,339
2026-09-21 2026-09-21 PrS Proposed sale

Director; Officer

Executive Director
422
8.19
US$3,456
422 8.19 US$3,456
2026-09-16 2026-09-14 PlS Planned sale

Chief Scientific Officer

Officer
4,000 -0.7%
7.88
US$31,538
4,000 -0.7% 7.88 US$31,538
2026-09-16 2026-09-14 PlS Planned sale

Chief Medical Officer

Officer
5,000 -2.3%
7.88
US$39,416
5,000 -2.3% 7.88 US$39,416
2026-09-14 2026-09-11 PlS Planned sale

Chief Legal Officer

Officer
6,168 -1.8%
7.63
US$47,089
6,168 -1.8% 7.63 US$47,089
2026-09-11 2026-09-11 PrS Proposed sale

Officer

Officer
6,168
7.61
US$46,938
6,168 7.61 US$46,938
2026-09-14 2026-09-10 PlS Planned sale

Executive Chairman

Executive Director
8,500 -0.2%
7.66
US$65,120
8,500 -0.2% 7.66 US$65,120
2026-09-10 2026-09-08 PlS Planned sale Non-Executive Director
6,250 -6.1%
8.13
US$50,818
6,250 -6.1% 8.13 US$50,818
2026-09-10 2026-09-08 PlS Planned sale Non-Executive Director
6,250 -6.1%
8.13
US$50,818
6,250 -6.1% 8.13 US$50,818
2026-08-31 2026-08-27 PlS Planned sale

Chief Scientific Officer

Officer
10,000 -1.8%
8.91
US$89,096
10,000 -1.8% 8.91 US$89,096
2026-08-27 2026-08-27 PrS Proposed sale

Officer

Officer
14,000
8.53
US$119,420
14,000 8.53 US$119,420
2026-08-26 2026-08-25 PlS Planned sale Non-Executive Director
6,250 -5.7%
8.68
US$54,233
6,250 -5.7% 8.68 US$54,233
2026-08-26 2026-08-25 PlS Planned sale

Chief Medical Officer

Officer
5,000 -2.3%
8.68
US$43,396
5,000 -2.3% 8.68 US$43,396
2026-08-25 2026-08-25 PrS Proposed sale

Director

Non-Executive Director
18,750
8.45
US$158,438
18,750 8.45 US$158,438
2026-08-26 2026-08-24 PlS Planned sale

Chief Technology Officer

Officer
5,000 -2.8%
8.80
US$44,000
5,000 -2.8% 8.80 US$44,000
2026-08-21 2026-08-21 PlS Planned sale

Chief Scientific Officer

Officer
5,408 -0.9%
8.40
US$45,447
5,408 -0.9% 8.40 US$45,447
2026-08-21 2026-08-20 PlS Planned sale

Chief Scientific Officer

Officer
4,592 -0.8%
8.41
US$38,609
4,592 -0.8% 8.41 US$38,609
2026-08-20 2026-08-20 PrS Proposed sale

Officer

Officer
6,000
8.28
US$49,680
6,000 8.28 US$49,680
2026-08-26 2026-08-19 PlS Planned sale

Chief Technology Officer

Officer
5,000 -2.7%
8.20
US$41,000
5,000 -2.7% 8.20 US$41,000
2026-08-21 2026-08-19 PlS Planned sale

Chief Scientific Officer

Officer
10,000 -1.7%
7.94
US$79,427
10,000 -1.7% 7.94 US$79,427
2026-08-21 2026-08-19 PlS Planned sale

Chief People Officer

Officer
10,000 -4.5%
7.94
US$79,439
10,000 -4.5% 7.94 US$79,439
2026-08-19 2026-08-19 PrS Proposed sale

Officer

Officer
10,000
7.62
US$76,200
10,000 7.62 US$76,200
2026-08-19 2026-08-19 PrS Proposed sale

Officer

Officer
8,000
7.62
US$60,960
8,000 7.62 US$60,960
2026-08-14 2026-08-13 PlS Planned sale

Chief Scientific Officer

Officer
4,000 -0.7%
7.52
US$30,076
4,000 -0.7% 7.52 US$30,076
2026-08-14 2026-08-12 PlS Planned sale

Chief Medical Officer

Officer
5,000 -2.2%
7.52
US$37,580
5,000 -2.2% 7.52 US$37,580
2026-08-10 2026-08-10 PlS Planned sale

Executive Chairman

Executive Director
8,500 -0.2%
7.61
US$64,669
8,500 -0.2% 7.61 US$64,669
2026-08-10 2026-08-07 PlS Planned sale

Executive Chairman

Executive Director
20,000 -0.6%
7.23
US$144,540
20,000 -0.6% 7.23 US$144,540
2026-08-10 2026-08-07 PlS Planned sale

Chief Technology Officer

Officer
5,000 -2.7%
7.60
US$38,000
5,000 -2.7% 7.60 US$38,000
2026-08-07 2026-08-07 PlS Planned sale

Chief Scientific Officer

Officer
10,000 -1.7%
7.48
US$74,759
10,000 -1.7% 7.48 US$74,759
2026-08-07 2026-08-07 PlS Planned sale

Chief Scientific Officer

Officer
7,000 -1.2%
7.02
US$49,152
7,000 -1.2% 7.02 US$49,152
2026-08-07 2026-08-07 PrS Proposed sale

Officer

Officer
22,000
6.69
US$147,180
22,000 6.69 US$147,180
2026-08-07 2026-08-07 PrS Proposed sale

Director; Officer

Executive Director
20,000
6.69
US$133,800
20,000 6.69 US$133,800
2026-08-07 2026-08-05 PlS Planned sale

Chief Scientific Officer

Officer
3,000 -0.5%
7.00
US$21,013
3,000 -0.5% 7.00 US$21,013
2026-08-05 2026-08-04 PlS Planned sale

Chief Scientific Officer

Officer
10,000 -1.6%
6.92
US$69,168
10,000 -1.6% 6.92 US$69,168
2026-08-05 2026-08-04 PlS Planned sale

Executive Chairman

Executive Director
20,000 -0.6%
6.92
US$138,412
20,000 -0.6% 6.92 US$138,412
2026-08-05 2026-08-04 PlS Planned sale

Chief Technology Officer

Officer
5,000 -2.6%
6.95
US$34,772
5,000 -2.6% 6.95 US$34,772
2026-08-04 2026-08-04 PrS Proposed sale

Officer

Officer
10,000
5.69
US$56,900
10,000 5.69 US$56,900
2026-08-04 2026-08-04 PrS Proposed sale

Director; Officer

Executive Director
20,000
5.69
US$113,800
20,000 5.69 US$113,800
2026-07-28 2026-07-27 PlS Planned sale

Chief Medical Officer

Officer
5,000 -2.2%
5.66
US$28,306
5,000 -2.2% 5.66 US$28,306
2026-07-22 2026-07-21 PlS Planned sale

Executive Chairman

Executive Director
20,000 -0.6%
6.63
US$132,654
20,000 -0.6% 6.63 US$132,654
2026-07-21 2026-07-21 PrS Proposed sale

Director; Officer

Executive Director
37,000
6.33
US$234,210
37,000 6.33 US$234,210
2026-07-22 2026-07-20 PlS Planned sale

Executive Chairman

Executive Director
4,581 -0.1%
6.17
US$28,244
4,581 -0.1% 6.17 US$28,244
2026-07-22 2026-07-20 PlS Planned sale

Executive Chairman

Executive Director
19,800 -0.6%
6.32
US$125,201
19,800 -0.6% 6.32 US$125,201

See older SOPHiA GENETICS SA insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock SOPHiA GENETICS SA history with Plus

Billed monthly · Cancel anytime